Improving access to opioid analgesics: Ukraine March 5-6, 2013 Vienna.

Slides:



Advertisements
Similar presentations
MEDICATIONS IN SCHOOLS: SECTION VI
Advertisements

Country Report for: ALBANIA DR. KRISTO HUTA. 2 Demographic Dat a Albania: Population Albania: Population »Year 1990: inhabitants. »Year 1990:
Introduction to Treat the Pain. The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain.
1 Potential & Actual Opioid Diversion in Vietnam, Methods of Preventing Diversion, and Barriers to “Balance” Eric Krakauer, MD, PhD Harvard Medical School.
Controlling Off-Label Narcotics Usage - Impact of New Arizona Legislation ARS §
CDER/CSS ALSDAC September 9-10, 2003 Risk Management and the Controlled Substances Act: The FDA Perspective Deborah B. Leiderman, M.D., M.A. Director Controlled.
Bylaw on drug demand reduction in Serbia. Bylaw(s) - principles  should be based on existing law(s)  should complement existing laws  should not be.
Management of Medicines and Pharmaceutical Supplies for use in the prevention and treatment of Pre-eclampsia and Eclampsia Grace Adeya, SPS/MSH February.
THE PRESENT EXPERIENCE AND CHALLENGES BEFORE THE BULGARIAN HEALTH INSURANCE SYSTEM IN THE FIELD OF HOSPITAL CARE Jeni Nacheva Director of Department for.
Prescription Drug Abuse Sharon Hertz, M.D. Medical Officer Division of Anesthetic, Critical Care and Addiction Drug Products Food and Drug Administration.
Abuse Liability of Hydromorphone Extended Release Capsules Silvia N. Calderon, Ph.D. Controlled Substance Staff Center for Drug Evaluation and Research.
Procedure for narcotic drugs use for medical purposes in the Republic of Kazakhstan.
Situation analysis in Kyrgyzstan Making Opioids Available in Eastern Europe and Central Asia March 5-6, 2013 Vienna.
Governmental, Legal and Regulatory Framework in Azerbaijan Republic Aysel Hasanova, Akbar Guliyev, Emin Mansurov Regional Workshop - School for Drafting.
March года Barcelona, Spain Tajikistan country presentation.
REGIONAL HEALTHCARE CENTER ASSOC. PROF. D-R PETKO SALCHEV PhD.
Research Activities to Document Progress During IPPF Aaron M. Gilson, MS, MSSW, PhD Research Program Manager/Senior Scientist Pain & Policy Studies Group.
RER/9/096 Regional Planning Meeting “Strengthening National Infrastructures for the Control of Radiation Sources” (TSA-1), (Phase II) Country: Kazakhstan.
Chapter 1. OBJECTIVES  see p-2 of text book KEY TERMS / CONCEPTS  controlled substances  Drug Enforcement Administration (DEA)  drug standards  Food.
ALL-UKRAINIAN PUBLIC ORGANIZATION “PUBLIC TRANSPORT SAFETY COMMITTEE”
The implementation of the National Tuberculosis Control Program at a regional level: Voronezh TB Service JULY 13, 2015 Dr. Kornienko, Sergey.
1 Accessibility of Opioids in the Republic of Kazakhstan G.U. Raimkulova – Head of Pharmaceutical Activities Administration, Medical and Pharmaceutical.
Country Report for: UKRAINE Natallia Datsiuk, MPH Bogomolets National Medical University Ukraine, Kyiv.
RER/9/096 Regional Planning Meeting “Strengthening National Infrastructures for the Control of Radiation Sources” (TSA-1), (Phase II) Republic of Moldova.
Current System of Drug Control In Georgia Prof. D. Kordzaia – Georgian National Association for Palliative Care VIENNA - March 5-6, 2013 “Making Oral Opioids.
“Improving opioid availability through advocacy” Experience from Serbia Snežana Bošnjak International Pain Policy Fellow ( ) Institute for Oncology.
Ministry of Health of the Republic of Armenia Feb 2013.
Description of the current system of drug control in Romania Prof. Daniela Mosoiu, MD, PhD Hospice Casa Sperantei Brasov, Romania.
Assembly Bill #2609 Health and Safety Code Effective January 1,2008 MEDICATION TRAINING FOR DIRECT CARE STAFF.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Country Report for:
Medicines and Service Availability and Accessibility in Cancer Care in Georgia 28 th August 2012 Tbilisi Tamari Rukhadze MD. PhD. Oncologist, International.
ACCESS TO MEDICINES - POLICY AND ISSUES
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Tajikistan Making Opioids Available in Eastern Europe and Central Asia March 5-6, 2013 Vienna.
Meg O’Brien, Ph.D. Director, Global Access to Pain Relief Initiative Procurement & Manufacture of IR Oral Morphine: Uganda experience 1.
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
Blood Transfusion Services in Uzbekistan Professor Dr. H.Y. Karimov Research Institute of Hematology and Blood Transfusion of the Ministry of Health, Republic.
STORAGE OF FLAMMABLE AND EXPLOSIVE SUBSTANCES. Medications and medical wares which possess inflammable and explosive characteristics are widely used in.
State Nuclear Regulatory Committee of Ukraine State Nuclear Regulatory Inspectorate of Ukraine Safety of radiation sources Unit of Radiation Safety.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
Dean R Hatt. Famous Quotes  “Drug misuse is not a disease, it is a decision, like the decision to step out in front of a moving car. You would call.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Draft Law of Kyrgyz Republic on Medicinal Products Syrdybaev Suyunbek, Head of expert group of ISWG of MoH KR 4 th Forum of МеТА Kyrgyz Republic Bishkek,
Ministry of Health of the Kyrgyz Republic The progress in the implementation of the Drug Circulation Program for ( The Decree of the Government.
Unit 5. THE ORGANIZATION OF PRESCRIPTION DEPARTMEN PHARMACY. RULES OF EXCERPTION AND RECEPTION OF RECIPE.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 30 –External Relations Bilateral screening:
1 M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 29 – Customs union Bilateral screening:
Safe Opioid Prescribing MedicinesDoseFrequencyRouteQuantity Morphine Sulphate MR 10mg tablets10mgBD OralSupply 28 tablets (Twenty eight tablets) Morphine.
Safe use of HYDROmorphone
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 1 – Free movement of goods Bilateral.
Implementation of The Russian Pharmacovigilance regulation Alexander Panin State Veterinary and Phytosanitary Surveillance Agency of the Russian Federation.
The Law of the KR «On making amendments and changes to certain legislative acts of the KR» 4 th MeTA Forum in the Kyrgyz Republic Bishkek, December 8,
II Volga specialized forum "Medicine. Pharmacy"
Quick Regulatory Guide
Governmental, Legal and Regulatory Framework in Azerbaijan Republic
New developments in alcohol and drug policy of the Russian Federation
Audit Opioid use in palliative patients on general hospital wards
Koshkina E.A., Smirnovskaya M.S.
Bilateral screening: Chapter 1
Froukje Harkes-Idzinga, Pharm. D
Safety of radiation sources
Change in legislation on alcohol, tobacco and drugs in Russia in 2016.
Republican Unitary Enterprise “Belarusian Nuclear Power Plant”
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Indispensable, adequately provided and not unduly restricted
The only solution that provides complete, 360° support
CH 20: PAIN NATIONAL DEPARTMENT OF HEALTH PRIMARY HEALTHCARE 2014
Alcohol and Drug Policy Changes in Russia – 2019
Situation analysis in Kyrgyzstan
PHARMACOVIGILANCE SYSTEM
Presentation transcript:

Improving access to opioid analgesics: Ukraine March 5-6, 2013 Vienna

Narcotic medical substances registered for pain relief in Ukraine INNForm of production Morphine sulfateTablets 5mg, 10mg Morphine hydrochloride Solution for injections: 10mg 1ml Codeine phosphateTablets : 30mg Tramadol 50mg tablets/capsule of fast effect 100mg/ml peroral solution 50 mg/ml solution for injections Rectal suppositories 100 mg each Methadone 5mg tablets 1mg/ml peroral solution Fentanyl Transdermal plaster 25mcg/hour, 50 mcg/hour, 75 mcg/hour, 100 mcg/hour Solution for injections, 0.05 mg/ml

Narcotic medical substances registered for pain relief in Ukraine INNForm of production Buprenorphine hydrochloride Solution for injections 0.3 mg/ml 1 ml each Sublingual tablets 0.2 mg, 0.4 mg, 2 mg, 4 mg, 8 mg Transdermal plaster 20 mg (35 mcg/hour), 30 mg (52.5 mcg/hour), 40 mg (70 mcg/hour) HydromorphoneProlonged-action tablet 8 mg, 16 mg, 32 mg Omnopon Solution for injections 1 ml in ampules (Morphine hydrochloride 11.5 mg, noscapin, papaverine hydrochloride, codein, tebaine) Promedol (trimeperidine hydrochloride) Solution for injections, 20 mg/ml 1 ml each Butorphanol tartrate Solution for injections0.2%

Registration of medical substances

- Expertise of registration materials - Development of medical standards, clinical protocols - Development of forms of MS State expert Center of MoH of Ukraine - Control of quality and safety of MS - Permission on import of unregistered substances - License on production, Лицензия на производство, wholesale and retail trade of MS State service of Ukraine on medical substances - Registration of MS -Order of prescription and selling of medicine Ministry of Health (MoH) Permission for using premises for circulation of narcotic substances Ministry of Internal Affairs of Ukraine (MIA)

CONTROL SYSTEM  State service on drug control (SSDC) - central body of executive power in sphere of forming and implementing politics on circulation of narcotic substances (NS) 1. Forms the list of narcotic substances, psychotropic and substances and precursors. 2. Issues licenses for carrying out activities with narcotic substances 3. Forms quota on NS based on MoH data 4. Issues Permission for import, export and transit of NS on territory of Ukraine

CONTROL SYSTEM  State service on drug control (SSDC) - central body of executive power in sphere of forming and implementing politics on circulation of narcotic substances (NS) 1. Forms the list of narcotic substances, psychotropic and substances and precursors. 2. Issues licenses for carrying out activities with narcotic substances 3. Forms quota on NS based on MoH data 4. Issues Permission for import, export and transit of NS on territory of Ukraine

Transportation of NS  Based on license  Performed by health institutions, actors which produce NS or carriers if they insure the security of cargo  With escort of responsible person  Within city or district without permission of MIA  In quantity more than 200kg - with escort of patrol car of State automobile Inspection or state guard service of MIA

Import  Permission for each separate operation issued by SSDC, coordinated with Security Service of Ukraine  State control of quality of MS

Storage in health institutions  Based on license  In separate rooms, equipped according to requirements of MIA (Order 216)

Pharmacy depot  Walls – equivalent of density of 500 mm brickwall  Floor and ceiling – armored concrete slab180mm or Strengthening the inside with grid-iron  Door - Metal or wooden (covered by sheet of iron on both sides) solid with two mortise locks– 40mm - Laced metal doors from inner side  Windows – screened  Multi-line security alarm system

Pharmacy and Medical Preventive Institution  Walls – equivalent of density of 500 mm brickwall  Floor and ceiling – armored concrete slab180mm or Strengthening the inside with grid-iron  Door - Metal or wooden (covered by sheet of iron on both sides) solid with two mortise locks– 40mm - Laced metal doors from inner side  Windows – screened  Alarm system along the perimeter of the room

Outpatients’ departments/Posts in Medical Preventive Institution  Separate room with safe or metallic cabinet fastened to floor (wall)  Doors – Metal or wooden (covered by sheet of iron on both sides) solid 40mm with two mortise locks  Windows – screened  Autonomic alarm system with output of alarm to posts of central surveillance or local sonic or light signaling devices

Prescription of NS Due to absence for a long time of peroral forms of morphine there is a fix practice that doctors do not give prescriptions for strong opiods and patients receive them in Medical Preventive Institutions Acting order of MoH №11Draft decree  Doctors according to position and existence of medical indications  Prescription is prohibited by doctor of different specialization with exception when there are no narrow-purpose specialists in the areas  Permission for prescription for more than three days is issued by commission on reasonability of prescription with further approval of chief doctor or deputy chief doctor  Prescribed by doctor or paramedic in defined cases  Prescription for more than 10 days is done by doctor with reasoning and writing in medical records

Prescription of NS  As a rule NS are prescribed by oncologists Acting order of MoH №11Draft decree Doctors according to position and existence of medical indications Prescription is prohibited by doctor of different specialization with exception when there are no narrow-purpose specialists in the areas Permission for prescription for more than three days is issued by commission on reasonability of prescription with further approval of chief doctor or deputy chief doctor Prescribed by doctor or paramedic in defined cases Prescription for more than 10 days is done by doctor with reasoning and writing in medical records

Use of NS Acting order of MoH №11Draft decree Patients receive Ns through MTI. Administration of parenteral forms is done only by medical personnel Other forms - without assistance according to prescription of doctor Patient or person who conducts care can receive substances in MTI or in pharmacy by prescription in the quantity not more that 10 day necessity norm

Prescriptions Decree of MoH 360Draft decree on making amendments Prescription blank is subject to strict reporting Certified by additional round-type signet of an institution and signed by head of MTI Maximum quantity in one prescription Morphine – 0.1g Tablets 10 mg Ampoules 1% 1ml In providing palliative care to patients it is allowed to prescribe on one prescription blank medical substances in quantity equal to 15 days necessity norm Validity of prescription – 5 days10 days Sold by pharmacies within one territorial region of MTI To exclude

Need in morphine for population of Ukraine according to official data in 2011 need: mg per day for 3 months Number of deaths because of oncologic diseases 2011 Number of deaths because of AIDS 2011 Number of patients who need pain relief Quantity of morphine (peroral), needed for pain relief (kg) 82,0623,71367,506410

Need in different forms of morphine  With fast effect  With prolonged action  Injection form  Syrups  Sprays  Candles  Patches

Thank You